siRNAgen Therapeutics

About

siRNAgen Therapeutics is a next-generation RNAi platform products company focused on immunology and central nervous system (CNS) diseases. Their proprietary SAMiRNA™ platform leverages modular chemistry to overcome the challenges around delivery. SAMiRNA™ platform has been instrumental in the creation of innovative drugs such as SRN-001, which holds immense promise in treating fibrotic diseases globally. With a firm commitment to innovation and collaboration, siRNAgen continues to push the boundaries of scientific discovery to change the lives of patients worldwide.

Product

Value proposition

Revolutionizing RNA therapeutics with curative, sustainable RNAi therapies for cancer, fibrosis, immunology and CNS

Founders

• Han-Oh Park — Founder and CEO

Technologies

Competitors

Investors

News

• siRNAgen Therapeutics is a subsidiary established in 2019 by Bioneer, a company specializing in mole.. - MK · 2026-03-08T07:08:16.000Z
• Bioneer and its subsidiary siRNAgen Therapeutics (siRNAgen) announced on the 24th that siRNA-based t.. - MK · 2025-01-24T00:10:00.000Z
• Bioneer and its subsidiary siRNAgen Therapeutics (siRNAgen) announced on the 26th that the siRNA tre.. - MK · 2024-08-26T00:43:24.000Z
• JLABS Korea is Rapidly Energizing the Local Innovation Ecosystem · 2024-08-23T00:00:00.000Z
• List of Gene Therapy Companies in Massachusetts - BiopharmIQ · 2025-06-04T00:00:00.000Z
• [Health Innovation②] JLABS introduces 'No Strings Attached' model... · 2024-10-17T00:00:00.000Z

Browse related software

• Clinic software in MA
• Clinic software in Cambridge
• All clinic software companies A–Z